Skip to content

Field construction for diagnosis tool inspection of colorectal cancer and precancerous lesions using newly developed biomarker

Field construction for diagnosis tool inspection of colorectal cancer and precancerous lesions using newly developed biomarker - Field construction for diagnosis tool inspection of colorectal cancer and precancerous lesions using newly developed biomarker(Oshima Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020277
Enrollment
2000
Registered
2015-12-19
Start date
2015-11-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Total colonoscopy, FIT and Blood test will be provided once for all participants.

Sponsors

National Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Residents in Oshima-machi, Tokyo

Exclusion criteria

Exclusion criteria: Non-assentor

Design outcomes

Primary

MeasureTime frame
Diagnostic sensitivity, specificity, PPV, NPV and overall accuracy of the FIT and newly developed biomarker for colorectal cancer and precancerous lesions (so called advanced adenoma, >10mm, HGD).

Secondary

MeasureTime frame
Safety and effectiveness of screening colonoscopy(complication rate, CRC detection rate and adenoma detection rate: ADR).

Countries

Japan

Contacts

Public ContactTakahisa Matsuda

National Cancer Center Hospital Cancer Screening Center

tamatsud@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026